| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.09▼ | 5.05▼ | 5.04▲ | 4.88▲ | 4.99▲ |
| MA10 | 5.05▼ | 5.06▼ | 5.04▲ | 4.79▲ | 6.35▼ |
| MA20 | 5.04▲ | 5.00▲ | 4.88▲ | 5.07▼ | 7.14▼ |
| MA50 | 5.02▲ | 4.81▲ | 4.75▲ | 6.59▼ | 9.37▼ |
| MA100 | 4.84▲ | 4.82▲ | 5.45▼ | 7.35▼ | 45.16▼ |
| MA200 | 4.79▲ | 6.21▼ | 6.54▼ | 8.95▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.004▼ | 0.022▲ | 0.094▲ | -0.013▼ |
| RSI | 50.089▲ | 54.500▲ | 56.345▲ | 41.057▼ | 37.264▼ |
| STOCH | 68.124 | 63.485 | 49.910 | 51.397 | 13.437▼ |
| WILL %R | -40.909 | -60.606 | -38.519 | -47.647 | -87.429▼ |
| CCI | 3.908 | -30.318 | 41.949 | 69.961 | -109.599▼ |
| CDL | $AVTX Doji Candlestick Pattern Detected | Set Alert |
|
Wednesday, April 30, 2025 04:00 AM
Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that Dr. Garry Neil, Chief Executive Officer of Avalo, ...
|
|
Monday, April 21, 2025 05:00 PM
Bank of Montreal Can bought a new position in Avalo Therapeutics, Inc. (NASDAQ:AVTX – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the ...
|
|
Monday, April 21, 2025 05:00 PM
Stay updated on market trends for AVTX. Avalo Therapeutics 'Represents An Attractive Pure-Play,' Analyst Initiates Coverage With Over 300% Stock Upside Avalo Therapeutics' AVTX-009 is advancing in ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 5.01 | 5.32 | 4.80 | 5.04 | 32,928 |
| 30/04/25 | 5.07 | 5.47 | 4.9156 | 4.98 | 64,492 |
| 29/04/25 | 4.90 | 4.98 | 4.85 | 4.86 | 38,472 |
| 28/04/25 | 4.88 | 4.88 | 4.53 | 4.73 | 39,093 |
| 25/04/25 | 4.80 | 4.89 | 4.63 | 4.78 | 23,054 |
| 24/04/25 | 5.08 | 5.08 | 4.77 | 4.88 | 38,256 |
| 23/04/25 | 5.00 | 5.26 | 4.795 | 4.95 | 45,535 |
| 22/04/25 | 4.40 | 4.97 | 4.40 | 4.87 | 75,384 |
| 21/04/25 | 4.34 | 4.77 | 4.15 | 4.41 | 87,214 |
| 17/04/25 | 4.66 | 4.9467 | 4.31 | 4.41 | 74,408 |
|
|
||||
|
|
||||
|
|